Bioworld Financial Watch articles from January 2008

Bioworld Financial Watch archives from January 2008

Cypress, forest NDA in FMS puts drug in line for 'churn'.(Patients Likely To Rotate Therapies)(Cypress Bioscience Inc. and Forest Laboratories Inc.'s new fibromyalgia syndrome drug)
January 7, 2008... When Pfizer Inc. won U.S. approval of its alpha-2 delta ligand Lyrica, people with fibromyalgia syndrome (FMS) gained their first official therapy for the painful, head-to-toe disorder, which brings a dreary lineup of added symptoms that...

Money raised by biotech in 2007 Vs. 2006.(biotechnology industries)(Table)(Brief article)
January 7, 2008... Money Raised By Biotech In 2007 Vs. 2006 Jan. 1-Dec. 31,2007: Jan. 1-Dec. 31, 2006: S24.774.19M S20.286.67M Public/other * 13,419 8,532 Private Biotechs...

10 biggest U.S. gainers for the week.(securities of pharmaceutical and biotechnology companies)(Table)(Brief article)
January 7, 2008... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Alliance Pharma 100.00 United Therapeutics 3.97 Ortec Intl. 60.61 Crucell N.V. 2.75 Palatin Techn 33.33 Celgene ...

10 biggest U.S. losers for the week.(securities of pharmaceutical companies)(Table)(Brief article)
January 7, 2008... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Cleveland BioLabs -59.54 Amicus -5.01 Amicus -31.87 Cleveland BioLabs -4.87 CytRx -24.82 OSI Pharma -3.92...

Public financing of biotechnology: December 2007.(biotechnology industries)(Table)
January 7, 2008... Public Financing Of Biotechnology: December 2007 I. COMMENCED TRADING IN DECEMBER Company Date Date Shares/Units Price Shares (Symbol) # Filed Comm. (M) Out (M) @ INITIAL OFFERINGS...

Other financings of public biotechnology companies: December 2007.(Table)
January 7, 2008... Other Financings Of Public Biotechnology Companies: December 2007 TOTAL: $749.91M Company Type Of Number Of Amount (Symbol) # Financing Shares, Units Raised Or...

Venture capital and other investments in private biotechnology companies: December 2007.(Table)
January 7, 2008... Venture Capital And Other Investments In Private Biotechnology Companies: December 2007 FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $402.8M Company Location Date Amt. (M) Abcellute Ltd. Cardiff,...

Milestone payments from corporate partners: December 2007.(pharmaceutical companies)(Table)
January 7, 2008... Milestone Payments From Corporate Partners: December 2007 TOTAL: $152.02M Year to Date: $1,151.37M Company Partner Amt. Triggering (Symbol) # * (Country) (M) Event Antares ...

Money raised by biotech in 2007: January-December.(biotechnology industry)(Table)(Brief article)
January 7, 2008... Money Raised By Biotech In 2007: January-December Type of Jan. Feb. March April May financing Public offerings 573.5 655.4 174.1 559.1 1,257.5 Private biotechs 518.7 763.5 798.7...

BioWorld Stock Indicator 2007.(Brief article)
January 7, 2008... These graphs compare the performance of the biotech stocks for all of 2007 using two different measures. The BioWorld Stock Indicator measures the average percent change year to date in the 307 U.S. biotech and biotech-related stocks that...

BioWorld stock report for public biotechnology companies.(Table)
January 7, 2008... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 12/28 1/04 WK YTD (000) Aastrom Biosci ASTM 0.55 0.6...

Departure Of CEO no cause for panic, ArQule reassures.(Stock Dented: Shades Of Anadys?)
January 14, 2008... The 22 percent-plus hit taken last week by ArQule Inc. last week signaled investor jitters on word that Stephen Hill, president and CEO, is stepping down as of March. Analysts sought to calm Wall Street, but observers hardly required long...

Money raised by Biotech in 2007 vs. 2006.(biotechnology industries)(Table)(Brief article)
January 14, 2008... Money Raised By Biotech In 2007 Vs. 2006 Jan. 1 - Jan. 10, 2008: Jan. 1 - Jan. 25, 2007: $355.70M $1,004.74M Public/Other * 229 326 ...

10 biggest U.S. gainers for the week.(Table)(Brief article)
January 14, 2008... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Pharmasset 80.27 Illumina 13.40 Emergent BioSol 54.11 Pharmasset 11.23 Helicos 43.69 Pharma Prdct Dev 5.72...

10 biggest U.S. losers for the week.(pharmaceutical companies)(Table)(Brief article)
January 14, 2008... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Cadence Pharma -61.44 Cadence Pharm -8.54 Amicus -31.87 Alexion Pharma -7.86 Neurogen -27.30 Amicus ...

Clinical trials update: December 2007.(Table)
January 14, 2008... Clinical Trials Update: December 2007 Company * (Country; Product Description Symbol) AUTOIMMUNE NicOx SA (France; Naproxcinod COX-inhibiting nitric FSE:NXO) oxide-donating...

American Society of Hematology (ASH) meeting clinical trials news: December 2007.(Table)
January 14, 2008... American Society Of Hematology (ASH) Meeting Clinical Trials News: December 2007 Company * (Country; Product Description Symbol) Bayer Healthcare AG Rivaroxaban Oral, once-daily (Germany) and ...

Non-U.S. clinical trials and regulatory actions: December 2007.(Table)
January 14, 2008... Non-U.S. Clinical Trials And Regulatory Actions: December 2007 Company * Product Description Indication (Country; Symbol) AUTOIMMUNE Abbott Humira Adalimumab; an Moderate-to-severe...

FDA submissions, approvals and other actions: December 2007.(Food and Drug Administration)(Table)
January 14, 2008... Company * Product Description (Country; Symbol) AUTOIMMUNE Anthera A-001 Intravenous sPLA2 inhibitor Pharmaceuticals Inc. * Centocor Inc. CNTO 1275 Ustekinumab (unit of...

BioWorld stock report for Public Biotechnology Companies.(Table)
January 14, 2008... Company Symbol Close Close %Change Vol 1/4 1/11 WK YTD (000) Aastrom Biosci ASTM 0.6 0.55 -8.33 5.77 3132 Acadia Pharma ACAD 10.45 12.16...

Second inhaled insulin down; firms, analysts keeping faith.(Novo Nordisk AS's decision to stop its inhaled insulin program)
January 21, 2008... The decision last week by Novo Nordisk AS to drop its Phase III inhaled-insulin program mildly stung licensor Aradigm Corp., putting observers in mind of Pfizer Inc.'s dump of Exubera in October - a surprise maneuver that dented shares of...

Money raised by biotech in 2007 Vs. 2006.(biotechnology industry)(Table)(Brief article)
January 21, 2008... Money Raised By Biotech In 2007 Vs. 2006 Jan. 1-Jan. 17, 2008: Jan. 1-Jan. 25, 2007: $634.20M $1,004.74M Public/Other * 257 326 Private Biotechs...

10 biggest U.S. gainers for the week.(pharmaceutical companies)(Table)(Brief article)
January 21, 2008... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Precent) (By Dollars) Compugen 43.55 Pharmasset 6.81 VioQuest Pharma 40.00 XenoPort 6.07 Cellegy Phanna 40.00 Lifecore...

10 biggest U.S. losers for the week.(securities of pharmaceutical companies)(Table)(Brief article)
January 21, 2008... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Oxis Intl. -40.00 Gen-Probe -4.76 SIGA Technologies -25.76 Biodel -4.40 Epix Pharma -23.06 ...

U.S. public offering performance by underwriter: January 1 - December 31, 2007.(Table)
January 21, 2008... U.S. Public Offering Performance By Underwriter: January 1 - December 31, 2007 * Underwriter Biotechnology Company Date Offering 12/31/07 priced price per SharePrice ...

BioWorld stock report for Public Biotechnology Companies.
January 21, 2008... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 1/11 1/18 WK YTD (000) Aastrom Biosci ASTM 0.55 ...

Vertex Phase III, HGS news spark ever-busy HCV space.(Chronic Patients Await a New Drug)(hepatitis C drug)
January 28, 2008... Vertex Pharmaceuticals Inc.'s unveiling last week of the Phase III program for the protease inhibitor telaprevir--the latest volley in the battle for a better hepatitis C virus therapy--brought cheers, muted somewhat by the inclusion of a...

Money raised by biotech in 2007 Vs. 2006.(Table)(Brief article)
January 28, 2008... Money Raised By Biotech In 2007 Vs. 2006 Jan. 1 - Jan. 24, 2008: Jan. 1 - Jan. 25, 2007: $914.95M $1,004.74M Public/Other * 283 326 ...

10 biggest U.S. gainers for the week.(pharmaceutical and biotechnology industries)(Table)(Brief article)
January 28, 2008... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Cleveland BioLabs 33.59 GTC Biothera 21.69 VioQuest Pharma 21.43 Neose Technologies 17.65 Oxis Intl. 16.67 CombinatoRx ...

10 biggest U.S. losers for the week.(pharmaceutical and biotechnology industries)(Table)(Brief article)
January 28, 2008... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Human Genome -44.35 Cellegy Pharma -28.57 BioCryst Pharma -20.45 Sunesis Pharma -20.38 Helicos -18.39 Vertex Pharma -15.92 Inspire...

U.S. public offering performance by underwriter: January 1--December 31, 2007 *.(Table)
January 28, 2008... ALL OFFERINGS, ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS * Underwriter Gross (Number Of Offerings As Lead/Number Proceeds Of Offerings As Lead Or Co-manager) (M) Morgan Stanley (11/12) ...

BioWorld stock report for public biotechnology companies.
January 28, 2008... BioWorld Stock Report For Public Biotechnology Companies Company SymbolSA Close Close %Change Vol 1/18 1/25 WK YTD (000) Aastrom Biosci ASTM 0.58...